Source link : https://www.newshealth.biz/health-news/will-fda-advisors-look-past-hypoglycemia-risk-with-once-weekly-insulin/
Concerns over hypoglycemia risk with an investigational once-weekly insulin product in patients with type 1 diabetes prompted the FDA to call an advisory committee together to weigh in on the matter. On Friday, the Endocrinologic and Metabolic Drugs Advisory Committee will discuss the long-acting insulin icodec by Novo Nordisk, which is seeking an indication for […]
Author : News Health
Publish date : 2024-05-22 20:53:56
Copyright for syndicated content belongs to the linked Source.